These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23731267)

  • 1. Glucose impairs B-1 cell function in diabetes.
    Jennbacken K; Ståhlman S; Grahnemo L; Wiklund O; Fogelstrand L
    Clin Exp Immunol; 2013 Oct; 174(1):129-38. PubMed ID: 23731267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
    Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
    Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.
    Haro MA; Dyevoich AM; Phipps JP; Haas KM
    Cancer Res; 2019 Jan; 79(1):159-170. PubMed ID: 30224373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells.
    Kawahara T; Ohdan H; Zhao G; Yang YG; Sykes M
    J Immunol; 2003 Nov; 171(10):5406-14. PubMed ID: 14607944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.
    Kyaw T; Tay C; Krishnamurthi S; Kanellakis P; Agrotis A; Tipping P; Bobik A; Toh BH
    Circ Res; 2011 Sep; 109(8):830-40. PubMed ID: 21868694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversification and CXCR4-Dependent Establishment of the Bone Marrow B-1a Cell Pool Governs Atheroprotective IgM Production Linked to Human Coronary Atherosclerosis.
    Upadhye A; Srikakulapu P; Gonen A; Hendrikx S; Perry HM; Nguyen A; McSkimming C; Marshall MA; Garmey JC; Taylor AM; Bender TP; Tsimikas S; Holodick NE; Rothstein TL; Witztum JL; McNamara CA
    Circ Res; 2019 Oct; 125(10):e55-e70. PubMed ID: 31549940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Zizimin2/3 in the age-related defect of peritoneal B-1a cells as a source of anti-bacterial IgM.
    Sakamoto A; Matsuda T; Kawaguchi K; Takaoka A; Maruyama M
    Int Immunol; 2017 Nov; 29(9):431-438. PubMed ID: 29099971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
    Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
    Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Role for C5a in B-1 Cell Homeostasis.
    Bröker K; Figge J; Magnusen AF; Manz RA; Köhl J; Karsten CM
    Front Immunol; 2018; 9():258. PubMed ID: 29520270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.
    Harmon DB; Srikakulapu P; Kaplan JL; Oldham SN; McSkimming C; Garmey JC; Perry HM; Kirby JL; Prohaska TA; Gonen A; Hallowell P; Schirmer B; Tsimikas S; Taylor AM; Witztum JL; McNamara CA
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):682-91. PubMed ID: 26868208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice.
    Sun J; Hartvigsen K; Chou MY; Zhang Y; Sukhova GK; Zhang J; Lopez-Ilasaca M; Diehl CJ; Yakov N; Harats D; George J; Witztum JL; Libby P; Ploegh H; Shi GP
    Circulation; 2010 Aug; 122(8):808-20. PubMed ID: 20697023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes.
    Hosseini H; Li Y; Kanellakis P; Tay C; Cao A; Tipping P; Bobik A; Toh BH; Kyaw T
    Cardiovasc Res; 2015 Jun; 106(3):443-52. PubMed ID: 25681396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Related Decline in Natural IgM Function: Diversification and Selection of the B-1a Cell Pool with Age.
    Holodick NE; Vizconde T; Hopkins TJ; Rothstein TL
    J Immunol; 2016 May; 196(10):4348-57. PubMed ID: 27183643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3Kγ ablation does not promote diabetes in
    Breasson L; Sardi C; Becattini B; Zani F; Solinas G
    FASEB J; 2018 Jan; 32(1):319-329. PubMed ID: 28904022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell developmental requirement for the G alpha i2 gene.
    Dalwadi H; Wei B; Schrage M; Spicher K; Su TT; Birnbaumer L; Rawlings DJ; Braun J
    J Immunol; 2003 Feb; 170(4):1707-15. PubMed ID: 12574334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice.
    Ohdan H; Swenson KG; Kruger Gray HS; Yang YG; Xu Y; Thall AD; Sykes M
    J Immunol; 2000 Nov; 165(10):5518-29. PubMed ID: 11067905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
    Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
    Case JB; Bonami RH; Nyhoff LE; Steinberg HE; Sullivan AM; Kendall PL
    J Immunol; 2015 Jul; 195(1):61-70. PubMed ID: 26034172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
    Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
    J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.